Tyson D. Murdock - 03 Apr 2023 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Apr 2023, 16:35:44 UTC
Prior SEC filing
31 Mar 2023
Next SEC filing
07 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tyson Murdock

Key filing fact

Tyson D. Murdock filed Form 4 for HEALTHEQUITY, INC. (HQY) on 05 Apr 2023.

Key facts

  • This page summarizes Tyson D. Murdock's Form 4 filing for HEALTHEQUITY, INC. (HQY).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Apr 2023, 16:35.

Change

  • Previous filing in this sequence was filed on 31 Mar 2023.
  • Current net transaction value: -$328,621.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HQY transaction

Common Stock

Tax liability

Transaction value
$159,711
Shares
-2,768
Change %
-3.5%
Price
$57.70
Shares after
76,830
Date
03 Apr 2023
Ownership
Direct
HQY transaction

Common Stock

Tax liability

Transaction value
$168,910
Shares
-3,017
Change %
-3.9%
Price
$55.99
Shares after
73,813
Date
04 Apr 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.9860 to $55.9861 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .